Copia Fund (Cayman) LP 13D/13G Filings for BriaCell Therapeutics Corp. (BCTX)

Copia Fund (Cayman) LP 13D and 13G filings for BriaCell Therapeutics Corp.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-01-08
11:01 am
Purchase
2023-12-29 13G BriaCell Therapeutics Corp.
BCTX
Copia Fund (Cayman) LP 54,558
5.100%
54,558increase
(New Position)
Filing